[Mechanism of changes in the duration of the phase of asynchronous contraction in patients with hypertensive disease and atherosclerosis].
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D005260:Female; D006145:Guanethidine / Q000627:therapeutic use; D006321:Heart / Q000503:physiopathology*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D008297:Male; D008715:Methionine / Q000627:therapeutic use; D008875:Middle Aged; D010946:Plants, Medicinal; D013835:Thiamine Pyrophosphate / Q000627:therapeutic use; D014498:Uracil / Q000627:therapeutic use
D000959:Antihypertensive Agents; D014498:Uracil; D008715:Methionine; D013835:Thiamine Pyrophosphate; D006145:Guanethidine
K voprosu o mekhanizme izmeneniĭ dlitel'nosti fazy asinkhronnogo sokrashcheniia y bol'nykh gipertonicheskoĭ bolezn'iu i aterosklerozom.